Particle News: Latest AstraZeneca news

AstraZeneca CEO Considers Shifting Primary Listing to U.S.

The proposal underscores CEO frustration with UK drug rules, facing board resistance, government opposition.

AstraZeneca’s Baxdrostat Delivers Significant Blood Pressure Reductions in Phase 3 Trial for Resistant Hypertension

Nvidia Partners with Swedish Consortium to Build Country’s Biggest Enterprise AI Supercomputer

NICE Approves Capivasertib for NHS Use in Advanced Breast Cancer Treatment

AstraZeneca Reports Strong 2024 Results While Facing China Tax Probe

FDA Launches PreCheck to Accelerate U.S. Drug Manufacturing Approvals

Campaigners Demand NHS Reform After Enhertu Price Talks Collapse

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030

Barcelona’s Revamped Estel Building Opens With 65% of Space Leased

IonQ Declares Quantum Supremacy Just Months Away

AstraZeneca Cancels £450m UK Vaccine Plant Investment

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

AstraZeneca H1 Revenue Jumps 11% as It Pledges $50 Billion U.S. Expansion

GSK Proposes Doubling CEO Emma Walmsley’s Pay to $27 Million

IonQ to Acquire Oxford Ionics for $1.075 Billion to Expand Quantum Capabilities

UK Finalizes £1bn BioNTech Deal to Advance mRNA Cancer Vaccines and AI Research

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Tempus AI Surpasses Q1 Expectations, Raises 2025 Revenue Guidance

AstraZeneca Deepens China Pact With $5.2 Billion CSPC Research Collaboration